{
    "nctId": "NCT03144648",
    "briefTitle": "PRECAMA: Molecular Subtypes of Premenopausal Breast Cancer in Latin American Women",
    "officialTitle": "Molecular Subtypes of Premenopausal Breast Cancer in Latin American Women (PRECAMA): a Multicenter Population-based Case-control Study",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer Female",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 3000,
    "primaryOutcomeMeasure": "breast cancer",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* woman between 20 and 45 years old\n* woman less than 3 years older or younger than the case\n* living in the area that the study is taking place during the past 3 years\n* woman menstruated at least once in the past 12 months\n* woman diagnosed with a primary breast cancer by histopathological examination (only for cases)\n\nExclusion Criteria:\n\n* woman receiving tumor treatment, such as radiotherapy, chemotherapy or anti-estrogens (for example, tamoxifen) (except treatment for non-melanoma skin cancers)\n* woman taking (or has previously taken) any of the following medications in the past 6 months: tamoxifen, Evista (raloxifene), Fareston (toremifene), Aromasin (exemestane), Femara (letrozole), Arimidez (anastrozole) or Megace (megestrol)\n* woman suffering from chronic kidney failure\n* woman having a pathology that will hinder adequate communication\n* woman who is pregnant or nursing\n* woman who has been previously diagnosed with a cancer(except for non-melanoma skin cancers)\n* any other reason to exclude",
    "sex": "FEMALE",
    "minimumAge": "20 Years",
    "stdAges": "ADULT"
}